Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC31479664;9665;9666 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
N2AB31479664;9665;9666 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
N2A31479664;9665;9666 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
N2B31019526;9527;9528 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
Novex-131019526;9527;9528 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
Novex-231019526;9527;9528 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516
Novex-331479664;9665;9666 chr2:178767791;178767790;178767789chr2:179632518;179632517;179632516

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Ig-22
  • Domain position: 1
  • Structural Position: 1
  • Q(SASA): 0.824
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs150283731 -0.099 0.02 N 0.213 0.073 None gnomAD-2.1.1 3.98E-06 None None None None N None 6.15E-05 0 None 0 0 None 0 None 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.919 likely_pathogenic 0.8911 pathogenic -1.364 Destabilizing 0.863 D 0.483 neutral N 0.315322813 None None N
V/C 0.9819 likely_pathogenic 0.9769 pathogenic -0.889 Destabilizing 0.999 D 0.526 neutral None None None None N
V/D 0.99 likely_pathogenic 0.989 pathogenic -1.13 Destabilizing 0.997 D 0.674 neutral N 0.318447777 None None N
V/E 0.9718 likely_pathogenic 0.9699 pathogenic -1.162 Destabilizing 0.998 D 0.625 neutral None None None None N
V/F 0.851 likely_pathogenic 0.8627 pathogenic -1.166 Destabilizing 0.982 D 0.516 neutral N 0.317257418 None None N
V/G 0.943 likely_pathogenic 0.9282 pathogenic -1.654 Destabilizing 0.997 D 0.677 prob.neutral N 0.317993073 None None N
V/H 0.9943 likely_pathogenic 0.9936 pathogenic -1.226 Destabilizing 0.999 D 0.662 neutral None None None None N
V/I 0.1016 likely_benign 0.1236 benign -0.684 Destabilizing 0.02 N 0.213 neutral N 0.353063661 None None N
V/K 0.9788 likely_pathogenic 0.9784 pathogenic -1.156 Destabilizing 0.993 D 0.628 neutral None None None None N
V/L 0.7595 likely_pathogenic 0.7799 pathogenic -0.684 Destabilizing 0.76 D 0.361 neutral N 0.314622626 None None N
V/M 0.6979 likely_pathogenic 0.7414 pathogenic -0.468 Destabilizing 0.986 D 0.473 neutral None None None None N
V/N 0.9716 likely_pathogenic 0.9696 pathogenic -0.861 Destabilizing 0.998 D 0.672 neutral None None None None N
V/P 0.9876 likely_pathogenic 0.9639 pathogenic -0.875 Destabilizing 0.998 D 0.605 neutral None None None None N
V/Q 0.9761 likely_pathogenic 0.9756 pathogenic -1.063 Destabilizing 0.998 D 0.615 neutral None None None None N
V/R 0.9706 likely_pathogenic 0.9674 pathogenic -0.613 Destabilizing 0.998 D 0.666 neutral None None None None N
V/S 0.9529 likely_pathogenic 0.9439 pathogenic -1.354 Destabilizing 0.993 D 0.595 neutral None None None None N
V/T 0.8385 likely_pathogenic 0.8305 pathogenic -1.277 Destabilizing 0.953 D 0.44 neutral None None None None N
V/W 0.9963 likely_pathogenic 0.996 pathogenic -1.323 Destabilizing 0.999 D 0.679 prob.neutral None None None None N
V/Y 0.9836 likely_pathogenic 0.9829 pathogenic -1.043 Destabilizing 0.998 D 0.499 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.